Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
[Information processing speed and influential factors in multiple sclerosis].
Glial cells as drug targets: What does it take?
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Preclinical studies of sex differences: a clinical perspective.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »